These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25500167)

  • 1. Bridging the gap between the neurocognitive lab and the addiction clinic.
    Franken IHA; van de Wetering BJM
    Addict Behav; 2015 May; 44():108-114. PubMed ID: 25500167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A transdiagnostic dimensional approach towards a neuropsychological assessment for addiction: an international Delphi consensus study.
    Yücel M; Oldenhof E; Ahmed SH; Belin D; Billieux J; Bowden-Jones H; Carter A; Chamberlain SR; Clark L; Connor J; Daglish M; Dom G; Dannon P; Duka T; Fernandez-Serrano MJ; Field M; Franken I; Goldstein RZ; Gonzalez R; Goudriaan AE; Grant JE; Gullo MJ; Hester R; Hodgins DC; Le Foll B; Lee RSC; Lingford-Hughes A; Lorenzetti V; Moeller SJ; Munafò MR; Odlaug B; Potenza MN; Segrave R; Sjoerds Z; Solowij N; van den Brink W; van Holst RJ; Voon V; Wiers R; Fontenelle LF; Verdejo-Garcia A
    Addiction; 2019 Jun; 114(6):1095-1109. PubMed ID: 30133930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contributions of cognitive neuroscience and neuroimaging to understanding mechanisms of behavior change in addiction.
    Morgenstern J; Naqvi NH; Debellis R; Breiter HC
    Psychol Addict Behav; 2013 Jun; 27(2):336-50. PubMed ID: 23586452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroscience of attentional processes for addiction medicine: from brain mechanisms to practical considerations.
    Fadardi JS; Cox WM; Rahmani A
    Prog Brain Res; 2016; 223():77-89. PubMed ID: 26806772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive-Behavioral Therapy.
    An H; He RH; Zheng YR; Tao R
    Adv Exp Med Biol; 2017; 1010():321-329. PubMed ID: 29098680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update in addiction medicine for the primary care clinician.
    Gordon AJ; Fiellin DA; Friedmann PD; Gourevitch MN; Kraemer KL; Arnsten JH; Saitz R;
    J Gen Intern Med; 2008 Dec; 23(12):2112-6. PubMed ID: 18830761
    [No Abstract]   [Full Text] [Related]  

  • 7. [Addiction--who is not affected?].
    Bäwert A; Fischer G
    Wien Med Wochenschr; 2005 Dec; 155(23-24):549-61. PubMed ID: 16425010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What Is Addiction? How Can Animal and Human Research Be Used to Advance Research, Diagnosis, and Treatment of Alcohol and Other Substance Use Disorders?
    Bickel WK; Crabbe JC; Sher KJ
    Alcohol Clin Exp Res; 2019 Jan; 43(1):6-21. PubMed ID: 30371956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Addiction].
    Besson J; Grivel J; Tomei A; Gothuey I; Andronicos M; Babel H; Nunweiler S
    Rev Med Suisse; 2013 Jan; 9(368):8-11. PubMed ID: 23367696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similarities and Differences in Psychology.
    Chen Y; Sun Y; Ai SZ; Li JJ; Lu L; Shi J
    Adv Exp Med Biol; 2017; 1010():91-101. PubMed ID: 29098670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotherapy.
    He RH; Tao R
    Adv Exp Med Biol; 2017; 1010():295-320. PubMed ID: 29098679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive Empowerment for Addiction Treatment (NEAT): study protocol for a randomized controlled trial.
    Ekhtiari H; Rezapour T; Sawyer B; Yeh HW; Kuplicki R; Tarrasch M; Paulus MP; Aupperle R
    Trials; 2021 May; 22(1):330. PubMed ID: 33962675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel, Expert-Endorsed, Neurocognitive Digital Assessment Tool for Addictive Disorders: Development and Validation Study.
    Lee RSC; Albertella L; Christensen E; Suo C; Segrave RA; Brydevall M; Kirkham R; Liu C; Fontenelle LF; Chamberlain SR; Rotaru K; Yücel M
    J Med Internet Res; 2023 Aug; 25():e44414. PubMed ID: 37624635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scaling Up Research on Drug Abuse and Addiction Through Social Media Big Data.
    Kim SJ; Marsch LA; Hancock JT; Das AK
    J Med Internet Res; 2017 Oct; 19(10):e353. PubMed ID: 29089287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives on neurocognitive rehabilitation as an adjunct treatment for addictive disorders: From cognitive improvement to relapse prevention.
    Rezapour T; DeVito EE; Sofuoglu M; Ekhtiari H
    Prog Brain Res; 2016; 224():345-69. PubMed ID: 26822366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognitive predictors of addiction-related outcomes: A systematic review of longitudinal studies.
    Christensen E; Brydevall M; Albertella L; Samarawickrama SK; Yücel M; Lee RSC
    Neurosci Biobehav Rev; 2023 Sep; 152():105295. PubMed ID: 37391111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of attentional bias modification for substance use disorder symptoms in adults: a systematic review.
    Heitmann J; Bennik EC; van Hemel-Ruiter ME; de Jong PJ
    Syst Rev; 2018 Oct; 7(1):160. PubMed ID: 30316302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions of mobile technologies to addiction research.
    Swendsen J
    Dialogues Clin Neurosci; 2016 Jun; 18(2):213-21. PubMed ID: 27489461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Event-Related Potentials as Biomarkers of Behavior Change Mechanisms in Substance Use Disorder Treatment.
    Houston RJ; Schlienz NJ
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 Jan; 3(1):30-40. PubMed ID: 29397076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cognitive remediation in addictions treatment].
    Pedrero-Perez EJ; Rojo-Mota G; Ruiz-Sanchez de Leon JM; Llanero-Luque M; Puerta-Garcia C
    Rev Neurol; 2011 Feb; 52(3):163-72. PubMed ID: 21287493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.